# Hydrogen sulfide promotes proliferation and regeneration of human cerebral microvascular endothelial cells via the sonic hedgehog signaling pathway

**Authors:** Hai-Yan Chen, Jian-Min Huang, Pin Zheng, Gui-Xin Yang, Bing-Bing Qin, Meng-Xue Zang, Jie Wang, Xue-Bin Li

PMC · DOI: 10.1515/biol-2025-1242 · Open Life Sciences · 2026-01-28

## TL;DR

Hydrogen sulfide helps brain blood vessel cells grow and recover under low oxygen by activating the SHH signaling pathway.

## Contribution

This study reveals a novel regulatory mechanism where H2S promotes endothelial cell regeneration via the SHH pathway under hypoxia.

## Key findings

- H2S and SHH increase VEGF and P-ERK1/2 while reducing apoptosis in HCMEC/D3 cells.
- H2S production by HMC3 cells is regulated by CBS and SHH proteins during hypoxia.
- Inhibiting SHH does not affect H2S levels, but CBS inhibition reduces both H2S and SHH.

## Abstract

We investigated the effects of hydrogen sulfide (H2S) and sonic hedgehog (SHH) on the proliferation, autophagy, and apoptosis of human microvascular endothelial cells (HCMEC/D3). We also explored the regulatory relationship between cystathionine-β-synthase (CBS) and the SHH pathway. Human microglia cells (HMC3) were stimulated under hypoxia to secrete H2S and SHH proteins, which were then co-cultured with HCMEC/D3 cells. The relationship between H2S and SHH was investigated by inhibiting the CBS or SHH pathways. Vascular endothelial growth factor (VEGF) and H2S levels were detected using ELISA. The mRNA and Protein levels of VEGF, Beclin-1, light chain 3 (LC3), Cysteine aspartic acid protease-3(caspase-3), CBS, SHH, extracellular regulated kinase 1/2 (ERK1/2) and phospho-ERK1/2 (P-ERK1/2) were determined by RT-PCR and western blot. The results indicated that H2S secretion by HMC3 increased during hypoxia, with both CBS and SHH proteins being up-regulated. The inhibition of CBS resulted in decreased levels of H2S and SHH in HMC3. When the SHH pathway is inhibited, H2S secretion levels remain unaffected. H2S and SHH proteins increased VEGF, P-ERK1/2, Beclin-1, and LC3 expression while reducing caspase-3 expression in HCMEC/D3 cells. H2S secretion by HMC3 promotes the proliferation and regeneration of HCMEC/D3 by regulating SHH protein and alleviating hypoxic injury.

## Linked entities

- **Genes:** CBS (cystathionine beta-synthase) [NCBI Gene 875], SHH (sonic hedgehog signaling molecule) [NCBI Gene 6469], VEGFA (vascular endothelial growth factor A) [NCBI Gene 7422], BECN1 (beclin 1) [NCBI Gene 8678], MAP1LC3A (microtubule associated protein 1 light chain 3 alpha) [NCBI Gene 84557], Casp3 (caspase 3) [NCBI Gene 12367], erk1/2 (mitogen-activated protein kinase) [NCBI Gene 778596], PERK12 (Protein kinase superfamily protein) [NCBI Gene 838963]
- **Proteins:** H2-S (histocompatibility 2, S region (C4, Slp, Bf, C2)), SHH (sonic hedgehog signaling molecule), VEGFA (vascular endothelial growth factor A), BECN1 (beclin 1), MAP1LC3A (microtubule associated protein 1 light chain 3 alpha), Casp3 (caspase 3), CBS (cystathionine beta-synthase), erk1/2 (mitogen-activated protein kinase), PERK12 (Protein kinase superfamily protein)
- **Chemicals:** hydrogen sulfide (PubChem CID 402)
- **Species:** Homo sapiens (taxon 9606)

## Full-text entities

- **Genes:** Gapdh (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 14433] {aka Gapd}, LRP6 (LDL receptor related protein 6) [NCBI Gene 4040] {aka ADCAD2, EVR8, OPTA4, STHAG7}, BECN1 (beclin 1) [NCBI Gene 8678] {aka ATG6, VPS30, beclin1}, GAPDH (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 2597] {aka G3PD, GAPD, HEL-S-162eP}, SHH (sonic hedgehog signaling molecule) [NCBI Gene 6469] {aka HHG1, HLP3, HPE3, MCOPCB5, SMMCI, ShhNC}, Fam72a (family with sequence similarity 72, member A) [NCBI Gene 108900] {aka 2700049P18Rik, P17}, CCND1 (cyclin D1) [NCBI Gene 595] {aka BCL1, D11S287E, PRAD1, U21B31}, HIF1A (hypoxia inducible factor 1 subunit alpha) [NCBI Gene 3091] {aka HIF-1-alpha, HIF-1A, HIF-1alpha, HIF1, HIF1-ALPHA, MOP1}, Shh (sonic hedgehog) [NCBI Gene 20423] {aka 9530036O11Rik, Dsh, HHG-1, Hhg1, Hx, Hxl3}, MPST (mercaptopyruvate sulfurtransferase) [NCBI Gene 4357] {aka MST, TST2, TUM1}, PTK2B (protein tyrosine kinase 2 beta) [NCBI Gene 2185] {aka CADTK, CAKB, FADK2, FAK2, PKB, PTK}, CBS (cystathionine beta-synthase) [NCBI Gene 875] {aka HIP4}, MAPK1 (mitogen-activated protein kinase 1) [NCBI Gene 5594] {aka ERK, ERK-2, ERK2, ERT1, MAPK2, NS13}, Il23a (interleukin 23, alpha subunit p19) [NCBI Gene 83430] {aka IL-23, p19}, MTOR (mechanistic target of rapamycin kinase) [NCBI Gene 2475] {aka FRAP, FRAP1, FRAP2, RAFT1, RAPT1, SKS}, CAT (catalase) [NCBI Gene 847], FGF2 (fibroblast growth factor 2) [NCBI Gene 2247] {aka BFGF, FGF-2, FGFB, HBGF-2}, NFE2L2 (NFE2 like bZIP transcription factor 2) [NCBI Gene 4780] {aka IMDDHH, NRF2, Nrf-2}, Cbs (cystathionine beta-synthase) [NCBI Gene 12411] {aka HIP4}, ANGPT2 (angiopoietin 2) [NCBI Gene 285] {aka AGPT2, ANG2, LMPHM10}, CASP3 (caspase 3) [NCBI Gene 836] {aka CPP32, CPP32B, SCA-1}, Map1lc3a (microtubule-associated protein 1 light chain 3 alpha) [NCBI Gene 66734] {aka 1010001H21Rik, 4922501H04Rik, LC3, LC3a}, ANGPT1 (angiopoietin 1) [NCBI Gene 284] {aka AGP1, AGPT, AGPT-1, ANG1, HAE5}, CSE [NCBI Gene 1433], VEGFA (vascular endothelial growth factor A) [NCBI Gene 7422] {aka L-VEGF, MVCD1, VEGF, VPF}, MAP1LC3A (microtubule associated protein 1 light chain 3 alpha) [NCBI Gene 84557] {aka ATG8E, LC3, LC3A, MAP1ALC3, MAP1BLC3}, GLI1 (GLI family zinc finger 1) [NCBI Gene 2735] {aka GLI, PAPA8, PPD1}, PTCH1 (patched 1) [NCBI Gene 5727] {aka BCNS, BCNS1, NBCCS, PTC, PTC1, PTCH}, AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, Casp3 (caspase 3) [NCBI Gene 12367] {aka A830040C14Rik, AC-3, CASP-3, CC3, CPP-32, CPP32}, CTH (cystathionine gamma-lyase) [NCBI Gene 1491] {aka CGL, CSE}, SMO (smoothened, frizzled class receptor) [NCBI Gene 6608] {aka CRJS, FZD11, Gx, PHLS, SMOH}, Becn1 (beclin 1, autophagy related) [NCBI Gene 56208] {aka Atg6}
- **Diseases:** infarct (MESH:D007238), necrosis (MESH:D009336), reperfusion injury (MESH:D015427), middle cerebral artery occlusion (MESH:D020244), atherosclerosis (MESH:D050197), CCVDs (MESH:D002318), Ischemic stroke (MESH:D002544), ischemic heart disease (MESH:D017202), endothelial injury (MESH:D057772), Hypoxic (MESH:D002534), stroke (MESH:D020521), neurological deficits (MESH:D009461), ischemia (MESH:D007511), Hypoxia (MESH:D000860), inflammatory (MESH:D007249), cancer (MESH:D009369), cerebral ischemia (MESH:D002545), neuroinflammation (MESH:D000090862)
- **Chemicals:** CO2 (MESH:D002245), glutathione (MESH:D005978), lipid (MESH:D008055), L-cysteine (MESH:D003545), sterol (MESH:D013261), Tween 20 (MESH:D011136), TBS-T (MESH:C027647), PVDF (MESH:C024865), AOAA (MESH:D000625), DMEM (-), H2S (MESH:D006862), oxime (MESH:D010091), disulfide (MESH:D004220), water (MESH:D014867), Ponceau S (MESH:C032756), SDS (MESH:D012967), Cyclopamine (MESH:C000541), cholesterol (MESH:D002784), cyclopropylamine (MESH:C067351), saline (MESH:D012965), polysulfides (MESH:C032915), O2 (MESH:D010100), CO (MESH:D002248), polyacrylamide (MESH:C016679)
- **Species:** Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]
- **Cell lines:** HCMEC/D3 — Homo sapiens (Human), Transformed cell line (CVCL_U985), HMC3 — Homo sapiens (Human), Transformed cell line (CVCL_II76)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12917562/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12917562/full.md

## References

48 references — full list in the complete paper: https://tomesphere.com/paper/PMC12917562/full.md

---
Source: https://tomesphere.com/paper/PMC12917562